Back to NewsPublished: 26 Dec 2025Download AppJoin TelegramAjanta Pharma’s Biocon Semaglutide Deal Could Add Rs2bn Sales – Investor Insight#Ajanta Pharma#Semaglutide#Pharma StocksDownload AppJoin CommunityShare Article